Medinfar awarded first ever CPHI Verified Certificate
CPHI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark
CPHI has awarded the first ever CPHI Verified certificate to Medinfar – an international pharmaceutical manufacturer of Rx, cosmetics, food supplements and veterinary products.
The new certification was given after a detailed evaluation by SGS – the world’s leading verification, inspection and certification company – spanning some 14 separate criteria, including the company’s approach to quality and environmental management, supply chain, health and safety and business continuity planning.
CPHI Verified, developed in partnership with SGS, empowers pharmaceutical buyers with an established benchmark of legal, regulatory, quality and brand pre-qualification compliance. The service forms part of the platinum membership on CPHI Online and is designed to further supply chain trust and transparency.
CPHI Online launched the service in response to customer requests for an easily recognisable global benchmark for quality and integrity, especially as companies seek to develop wider networks of global partners.
“We congratulate Medinfar on becoming the first CPHI Verified manufacturer, its well-deserved recognition of the quality of their credentials and we look forward to building a database of trusted suppliers," said Patrick Steenvoorden, Digital Director at CPHI.
“We have partnered on this programme with CPHI, the largest pharmaceutical trade show organiser and online community, to help suppliers communicate their level of compliance and adherence to various criteria. We are so pleased to welcome the very first partner to the CPHI Verified family and commend the Medinfar team on this achievement,” commented Kristofer Whitfield, Head of Delivery at SGS.
For more information about CPHI Verified, please visit CPHI Online – the largest and most trusted marketplace and content hub available to pharma professionals.
Related News
-
News How to disrupt an industry as big as pharma for the better?
In this interview, hear from Matthew Wise, Head of Data at CCD Partners, on the companies they've been looking into that are offering new and interesting perspectives that have the potential to shake up the pharmaceutical industry, and how they'... -
News CPHI Pharma Awards 2024: Meet the winners from the CPHI Celebration
This year we had a lot to celebrate, the 35th Anniversary of CPHI, and our esteemed award winners, of which we included two additional categories this year, the Future Leader award, and Woman of the Year award. -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
News A Day in the Life of a Global CDMO Chapter Lead – Manufacturing
The 'Day in the Life of' series has covered many aspects of the pharmaceutical pipeline, including R&D and procurement, now we're taking a look at manufacturing from a global CDMO perspective. -
News Eisai Alzheimer’s drug authorised in UK but still faces obstacles
In partnership with BioArctic AB, pharmaceutical company Eisai has been granted Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for its Alzheimer’s disease drug product Leqembi. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance